These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1673051

  • 21. A randomised, double-blind study of cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis.
    Lau CS, Belch JJ, Madhok R, Cappell H, Herrick A, Jayson M, Thompson JM.
    Clin Exp Rheumatol; 1993; 11(1):35-40. PubMed ID: 8453795
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Assessment of pinacidil in patients with primary Raynaud's phenomenon.
    Dompeling EC, Smit AJ.
    Vasa Suppl; 1992; 34():34-7. PubMed ID: 1529416
    [Abstract] [Full Text] [Related]

  • 24. Discontinuing long-term Iloprost treatment for Raynaud's Phenomenon and systemic sclerosis: a single-center, randomized, placebo-controlled, double-blind study.
    Bali G, Schwantzer G, Aberer F, Kraenke B, Aberer E.
    Acta Dermatovenerol Alp Pannonica Adriat; 2011; 20(1):13-21. PubMed ID: 21879200
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Action of Buflomedil on the cutaneous microcirculation studies by a cold provocation test. Multicenter, double-blind, placebo controlled trial].
    Maurel A, Betrancourt JC, Van Frenkel R, Thuillez C.
    J Mal Vasc; 1995; 20(2):127-33. PubMed ID: 7650439
    [Abstract] [Full Text] [Related]

  • 27. [Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].
    Correa MJ, Mariz HA, Andrade LE, Kayser C.
    Rev Bras Reumatol; 2014; 54(6):452-8. PubMed ID: 25458027
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T, Kelbaek H, Hartling OJ, Nielsen SL.
    Am Heart J; 1986 Apr; 111(4):742-5. PubMed ID: 3513504
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nifedipine in the treatment of idiopathic Raynaud's syndrome.
    Sarkozi J, Bookman AA, Mahon W, Ramsay C, Detsky AS, Keystone EC.
    J Rheumatol; 1986 Apr; 13(2):331-6. PubMed ID: 3723496
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Oral buflomedil in diabetic background retinopathy: results of a preliminary controlled study.
    Ducrey N, Curchod B.
    J Int Med Res; 1984 Apr; 12(3):184-7. PubMed ID: 6734921
    [Abstract] [Full Text] [Related]

  • 36. The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial.
    Muir AH, Robb R, McLaren M, Daly F, Belch JJ.
    Vasc Med; 2002 Apr; 7(4):265-7. PubMed ID: 12710841
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The combination of repeated anesthetic "bathing" of the cervico-thoracic system and buflomedil in analgesic therapy of in Raynaud's syndrome of the arm].
    Bonezzi C, Navazio Cassa G, Sangiovanni G, Brambilla GL.
    Minerva Cardioangiol; 1985 Oct; 33(10):655-7. PubMed ID: 4080170
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.